氰基丙烯酸酯胶粘剂治疗大隐静脉功能不全的首例人体36个月随访
这项前瞻性单臂单中心可行性研究评估了氰基丙烯酸酯(CA)胶粘剂闭合功能不全大隐静脉的36个月安全性和有效性。36个月时随访29例,闭合率94.7%(95%CI 87.9%-100%),VCSS从基线6.1±2.7改善至2.2±0.4(P<.0001),不良事件均为轻中度且自限。
要点
- CA胶粘剂36个月闭合率达94.7%,与热消融和非热方法相当。
- VCSS从基线6.1±2.7显著改善至36个月2.2±0.4(P<.0001)。
- 不良事件均为轻中度且自限,无严重不良事件报告。
核心结论
- CA胶粘剂似乎是安全有效的大隐静脉闭合治疗方法,长期闭合率与其他热性和非热性方法相当,且无严重不良事件报告。
主要发现
- 36个月时29例可随访,除2例分别在1个月和3个月出现再通外,所有受试者经双功超声确认完全闭合。
- Kaplan-Meier分析显示36个月闭合率为94.7%(95%CI 87.9%-100%)。
- 平均VCSS从基线6.1±2.7改善至36个月2.2±0.4(P<.0001)。
- 36个月时疼痛、水肿和静脉曲张(VCSS子域)分别改善75.9%、62.1%和41.4%。
- 总体不良事件为轻中度且自限。
临床怎么用
- CA胶粘剂可作为大隐静脉功能不全的闭合治疗选择,无需肿胀麻醉或术后弹力袜。
局限性
- 单臂、单中心、小样本可行性研究,36个月时仅29例可随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to evaluate the long-term safety and effectiveness of endovenous cyanoacrylate (CA)-based closure of incompetent great saphenous veins. METHODS: This was a prospective, single-arm, single-center feasibility study conducted at the Canela Clinic (La Romana, Dominican Republic) to assess the effectiveness and safety of a CA-based adhesive for great saphenous vein closure at 36 months after treatment. Thirty-eight subjects were treated by injection of small boluses of CA under ultrasound guidance and without the use of perivenous tumescent anesthesia or postprocedure graduated compression stockings. Periodic scheduled follow-up was performed during 36 months. RESULTS: At month 36, there were 29 subjects who were available for follow-up. Complete occlusion of the treated veins was confirmed by duplex ultrasound in all subjects with the exception of two subjects showing recanalization at month 1 and month 3. Kaplan-Meier analysis revealed an occlusion rate at month 36 of 94.7% (95% confidence interval, 87.9%-100%). The mean Venous Clinical Severity Score (VCSS) improved from 6.1 ± 2.7 at baseline to 2.2 ± 0.4 at month 36 (P < .0001). Pain, edema, and varicosities (VCSS subdomains) improved in 75.9%, 62.1%, and 41.4% of subjects, respectively, at month 36. Overall adverse events were mild or moderate and self-limited. CONCLUSIONS: CA adhesive appears to be an effective and safe treatment for saphenous vein closure, with long-term occlusion rates comparable to those of other thermal and nonthermal methods and with no reported serious adverse events.
引用
- Almeida JI, Javier JJ, Mackay EG, et al. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28818217. doi:10.1016/j.jvsv.2017.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。